Does cMV retinitis recur after stopping treatment in virological and immunological failures of potent antiretroviral therapy?
CMV disease recurs after virological and immunological failure of HAART if CD4 cell counts drop below 50. In this situation, anti-CMV agents should be resumed before clinical reactivation ensues, because of the risk of contralateral retinal involvement and systemic disease.
High NLR and PLR during the first trimester are independent predictors of subsequent preeclampsia.